Anebulo Pharmaceuticals (ANEB) Institutional Ownership $1.31 +0.01 (+0.77%) (As of 12/17/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Anebulo Pharmaceuticals (NASDAQ:ANEB)CurrentInstitutional OwnershipPercentage28.40%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$70.89K Get ANEB Insider Trade Alerts Want to know when executives and insiders are buying or selling Anebulo Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ANEB Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Anebulo Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/16/2024 LVW Advisors LLC643,039$1.56M0.3%-4.4%2.509% 2/8/2023Herr Investment Group LLC29,644$72K0.0%N/A0.116% 11/10/2022 Nantahala Capital Management LLC511,073$1.43M0.1%N/A1.994% 10/14/2022 LVW Advisors LLC674,964$1.89M0.4%-3.6%2.888% 7/22/2022 LVW Advisors LLC700,000$3.64M0.7%N/A2.999% 8/18/2021 Ikarian Capital LLC174,811$1.20M0.1%N/A0.749% 8/17/2021 22NW LP3,343,565$22.80M6.1%N/A14.322% 8/17/2021 Boothbay Fund Management LLC19,835$135K0.0%N/A0.085% 8/13/2021 Laurion Capital Management LP225,000$1.55M0.0%N/A0.964% (Data available from 1/1/2016 forward) ANEB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ANEB shares? During the previous two years, the following institutional investors and hedge funds held shares of Anebulo Pharmaceuticals shares: LVW Advisors LLC ($1.56M), Herr Investment Group LLC ($72K).Learn more on ANEB's institutional investors. What percentage of Anebulo Pharmaceuticals stock is owned by institutional investors? 28.40% of Anebulo Pharmaceuticals stock is owned by institutional investors. Learn more on ANEB's institutional investor holdings. Which institutional investors have been buying Anebulo Pharmaceuticals stock? The following institutional investors have purchased Anebulo Pharmaceuticals stock in the last 24 months: Herr Investment Group LLC ($29.64K). How much institutional buying is happening at Anebulo Pharmaceuticals? Institutional investors have bought a total of 29,644 shares in the last 24 months. This purchase volume represents approximately $71.85K in transactions. Which Anebulo Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Anebulo Pharmaceuticals stock in the last 24 months: LVW Advisors LLC ($29.29K). How much institutional selling is happening at Anebulo Pharmaceuticals? Institutional investors have sold a total of 29,292 shares in the last 24 months. This volume of shares sold represents approximately $70.89K in transactions. Related Companies Atossa Therapeutics Major Shareholders Applied Therapeutics Major Shareholders Enanta Pharmaceuticals Major Shareholders Vaxart Major Shareholders Cabaletta Bio Major Shareholders Protalix BioTherapeutics Major Shareholders Cassava Sciences Major Shareholders Inventiva Major Shareholders Editas Medicine Major Shareholders Aligos Therapeutics Major Shareholders This page (NASDAQ:ANEB) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anebulo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
